Joyce Liu – UF Innovate https://innovate.research.ufl.edu Building business on innovation Fri, 21 Nov 2025 17:49:19 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 https://innovate.research.ufl.edu/wp-content/uploads/favicon-blue_1.png Joyce Liu – UF Innovate https://innovate.research.ufl.edu 32 32 Dialectic Therapeutics Announces Dosing of First Patient in Platinum-Resistant Ovarian Cancer (PR Newswire) https://innovate.research.ufl.edu/dialectic-therapeutics-announces-dosing-of-first-patient-in-platinum-resistant-ovarian-cancer/ Fri, 21 Nov 2025 17:48:57 +0000 https://innovate.research.ufl.edu/?p=20722 UF startup Dialectic Therapeutics, Inc., a clinical-stage biotechnology company developing innovative anti-cancer drugs, announced that patient dosing is underway in a clinical trial led by the renowned Drs. Elizabeth Stover, Joyce Liu, and Ursula Matulonis from the Dana-Farber Cancer Institute. Dr. Matulonis previously served as the Principal Investigator for the study that led to a recent FDA approval in platinum-resistant ovarian cancer (PROC).

 

Read more about Dialectic Therapeutics Announces Dosing of First Patient in Platinum-Resistant Ovarian Cancer (PROC).

]]>